pharma news

News

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Daiichi Sankyo has agreed to sell its consumer health unit to food and beverage giant Suntory, following a well-trodden path for big pharma companies.

News

Parkinson's charity partners Biognosys on biomarker project

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

Amazon launches its AI drug discovery platform

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.

News

FDA seeks safety data for Lilly's oral GLP-1 Foundayo

The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.

News

FDA renews criticism of trial sponsors over transparency

The FDA has launched a drive to get clinical trial sponsors to disclose the results of studies – even if they are negative.

News

Novo Nordisk partners OpenAI on R&D "transformation"

Seeking an R&D edge, Novo Nordisk has become the latest big pharma group to forge an alliance with tech giant OpenAI.

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Parkinson's charity partners Biognosys on biomarker project

Amazon launches its AI drug discovery platform

FDA seeks safety data for Lilly's oral GLP-1 Foundayo

FDA renews criticism of trial sponsors over transparency

Novo Nordisk partners OpenAI on R&D "transformation"

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks